2-[4-(2,3-Dimethylphenyl)piperazin-1-yl]ethanamine → 3-{2-[4-(2,3-Dimethylphenyl)piperazin-1-yl]ethyl}aminomethyl-5-methyl-1-phenylpyrazole
Reaktionsgleichung
[CH3:1][C:2]1[C:7]([CH3:8])=[CH:6][CH:5]=[CH:4][C:3]=1[N:9]1[CH2:14][CH2:13][N:12]([CH2:15][CH2:16][NH2:17])[CH2:11][CH2:10]1.[CH3:18][C:19]1[N:23]([C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)[N:22]=[C:21]([CH:30]=O)[CH:20]=1>>[CH3:1][C:2]1[C:7]([CH3:8])=[CH:6][CH:5]=[CH:4][C:3]=1[N:9]1[CH2:10][CH2:11][N:12]([CH2:15][CH2:16][NH:17][CH2:30][C:21]2[CH:20]=[C:19]([CH3:18])[N:23]([C:24]3[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=3)[N:22]=2)[CH2:13][CH2:14]1Komponenten
3
Versuchsvorschrift
Compound 14 was prepared using the same method as that of Example 1 except that 4-(2,3-dimethylphenyl)piperazin-1-ylethylamine and 5-methyl-1-phenylpyrazole-3-carbaldehyde were used.
Quellen und Nachweise
- ORD-Eintrag
- ord-f1ed16cfdefc49efa73d3fd3014b5365
- Quelldatensatz
- uspto-grants-2009_06